Of these, Tagln2 has previously been linked to angiogenesis, proliferation, migration, and epithelial–mesenchymal transition in GC [25,26], while Mbl2 gene variants have been linked to risk of stomach cancer [27] and increased serum levels linked to pancreatic cancer [28]. Here, TAGLN2 is linked to familial pancreatic carcinoma.